Dyadic International Inc. (NASDAQ:DYAI) was up 13% after an intraday surge of more than 62%. The biotech company is focused on enhancing, deploying, and improving its novel C1-cell protein manufacture platform to expedite development, improve biologic drugs and vaccine development, and lower production costs. The trigger for the jump is the announcement that the company …
Continue reading “Dyadic International Inc. (NASDAQ:DYAI) Stock Turns Volatile: Here is Why”